Questions discussed in this category
What is the cost and accessibility of CYP2C19 gene testing? Does the limited availability of rapid genotyping techniques limit the clinical applicabil...
How do you plan to incorporate the results of the CHANCE-2 trial (Wang et al., PMID 34708996) in your own practice?
For instance, if the patient doesn’t tolerate apnea testing, is too unstable to go for ancillary testing outside the ICU, and TCDs/EEG are unava...
What factors influence your thinking?
Is there any benefit to starting hyperosmolar therapy prior to the development of depressed level of consciousness or midline shift?
What modality do you prefer?
What modality do you prefer?
13100130991004012997129731274712293121811024110214113391133710433
Papers discussed in this category
Neurotherapeutics,
The Lancet. Neurology, 2016-05
JAMA,
Contemp Neurol Ser,
N Engl J Med, 2021 Oct 28
The New England journal of medicine, 2018-07-19
N Engl J Med, 2013 Jun 26
N Engl J Med,